Drexel Morgan & Co’s Merck MRK Stock Holding History

Drexel Morgan & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Hold	132,292	–	–	2.33%	13
2025 Q4	$13.9M	Hold	132,292	–	–	2.18%	12
2025 Q3	$11.1M	Hold	132,292	–	–	1.74%	16
2025 Q2	$10.5M	Buy	132,292 +103,000	+352%	+$8.19M	1.86%	15
2025 Q1	$2.63M	Hold	29,292	–	–	0.55%	28
2024 Q4	$2.91M	Hold	29,292	–	–	0.6%	26
2024 Q3	$3.33M	Hold	29,292	–	–	0.62%	25
2024 Q2	$3.63M	Buy	29,292 +413	+1%	+$53.2K	0.78%	21
2024 Q1	$3.81M	Hold	28,879	–	–	0.78%	22
2023 Q4	$3.15M	Buy	28,879 +2,281	+9%	+$237K	0.73%	23
2023 Q3	$2.74M	Buy	26,598 +475	+2%	+$51.2K	0.75%	24
2023 Q2	$3.01M	Hold	26,123	–	–	0.78%	24
2023 Q1	$2.78M	Hold	26,123	–	–	0.7%	24
2022 Q4	$2.9M	Hold	26,123	–	–	0.6%	25
2022 Q3	$2.25M	Buy	26,123 +500	+2%	+$44.6K	0.54%	25
2022 Q2	$2.34M	Buy	25,623 +650	+3%	+$57.6K	0.64%	24
2022 Q1	$2.05M	Buy	24,973 +3,768	+18%	+$297K	0.6%	26
2021 Q4	$1.63M	Hold	21,205	–	–	0.47%	30
2021 Q3	$1.59M	Sell	21,205 -1,386	-6%	-$105K	0.51%	30
2021 Q2	$1.76M	Sell	22,591 -2,348	-9%	-$175K	0.52%	33
2021 Q1	$1.83M	Sell	24,939 -8	-0%	-$590	0.47%	40
2020 Q4	$1.95M	Hold	24,947	–	–	0.53%	37
2020 Q3	$1.98M	Buy	24,947 +5	+0%	+$392	0.69%	38
2020 Q2	$1.84M	Buy	24,942 +97	+0.4%	+$7.3K	0.7%	37
2020 Q1	$1.82M	Buy	24,845 +1,258	+5%	+$98.9K	0.71%	33
2019 Q4	$2.05M	Sell	23,587 -2,441	-9%	-$200K	1.54%	19
2019 Q3	$2.09M	Buy	26,028 +6	+0%	+$481	1.61%	23
2019 Q2	$2.08M	Sell	26,022 -615	-2%	-$47.1K	1.6%	22
2019 Q1	$2.11M	Buy	26,637 +687	+3%	+$51.4K	1.88%	17
2018 Q4	$1.89M	Buy	25,950 +1,781	+7%	+$126K	1.89%	18
2018 Q3	$1.64M	Buy	24,169 +101	+0.4%	+$6.43K	1.44%	33
2018 Q2	$1.39M	Buy	24,068 +1,928	+9%	+$109K	1.4%	35
2018 Q1	$1.15M	Sell	22,140 -6,300	-22%	-$340K	1.2%	35
2017 Q4	$1.53M	Buy	28,440 +7,090	+33%	+$393K	1.48%	28
2017 Q3	$1.3M	Sell	21,350 -493	-2%	-$29.9K	1.34%	31
2017 Q2	$1.34M	Buy	21,843 +345	+2%	+$21K	1.37%	34
2017 Q1	$1.3M	Buy	21,498 +10,944	+104%	+$664K	1.44%	30
2016 Q4	$593K	Buy	+10,554	New	+$618K	0.7%	44
2014 Q3	–	Sell	-7,624	Closed	-$421K	–	90
2014 Q2	$421K	Hold	7,624	–	–	0.51%	58
2014 Q1	$413K	Buy	7,624 +105	+1%	+$5.44K	0.52%	51
2013 Q4	$359K	Hold	7,519	–	–	0.48%	56
2013 Q3	$341K	Sell	7,519 -1,232	-14%	-$56.3K	0.47%	58
2013 Q2	$388K	Buy	+8,751	New	+$391K	0.64%	47

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Drexel Morgan & Co's MRK Position: Q1 2026 in Review

Drexel Morgan & Co held its Merck (MRK) position steady in Q1 2026 at 132,292 shares worth $15.9M. The position accounts for 2.33% of the portfolio, ranked #13.

Drexel Morgan & Co first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Drexel Morgan & Co held 132,292 shares of Merck worth $15.9M as of Q1 2026.
Drexel Morgan & Co left its Merck share count unchanged in Q1 2026.
Merck made up 2.33% of Drexel Morgan & Co's portfolio in Q1 2026, its #13 holding.
Drexel Morgan & Co first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.